Since TSPX overexpression significantly suppressed these genes in cultured NSCLC cells (Figure 4), we propose that TSPX suppresses these genes to inhibit the initiation and progression of lung adenocarcinoma under clinical conditions. This evidence concerns the gene TSPYL2 and non-small cell lung carcinoma.